Longeveron Profit Margin

The latest profit margin for LGVN is -1977.59% as of June 2026. That compares with -901.5% in the prior-year period — down 119.4% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Longeveron's historical trend and sector peers before judging valuation or financial health.

Over the past year, LGVN's profit margin moved from -901.5% to -1977.59% — a 119.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Longeveron's valuation or profitability profile.

Against Healthcare companies, LGVN currently prints -1977.59% for profit margin, while the sector average sits near 13.89%. That is roughly 14334.4% below the sector mean. Large gaps often invite a closer look at Longeveron's growth, margins, and balance sheet.

Profit Margin shows how effectively Longeveron converts resources into returns. At -1977.59%, LGVN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -901.5% in the prior-year period — down 119.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LGVN's profit margin (-1977.59%), review year-over-year change from -901.5%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.